Cite
HARVARD Citation
Largeaud, L. et al. (2020). Outcome of relapsed/refractory AML patients with IDH1R132 mutations in real life before the era of IDH1 inhibitors. Leukemia & lymphoma. 61 (2), pp. 473-476. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Largeaud, L. et al. (2020). Outcome of relapsed/refractory AML patients with IDH1R132 mutations in real life before the era of IDH1 inhibitors. Leukemia & lymphoma. 61 (2), pp. 473-476. [Online].